@incollection{,
	
					
					
					0A0956F2D33B4B2E0521F268B2A91F7B
				,
	author={{Dr. Ashfaq ulHassan} and {Dr. ShaziaNazir} and {SKIMS}},
	journal={{Global Journal of Medical Research}},
	journal={{GJMR}}2249-46180975-588810.34257/GJMR,
	address={Cambridge, United States},
	publisher={Global Journals Organisation}1531923
}

@incollection{b0,
	
	
		,
	title={{Animal models of syndrome X. Current Topics in}}
		,
	author={{
			EShafrir
		}}
	
	
		,
	journal={{Diabetes Research}}
		
			12
			
			,
	year={1993}
		
	

}

@incollection{b1,
	
	
		,
	title={{Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men}}
		,
	author={{
			PLempiainen
		}}
	
	
		,
	journal={{Circulation}}
		
			100
			2
			
			,
	year={1999}
		
	

}

@book{b2,
	
	
		,
	title={{Executive Summary of the Thyroid Report of National Cholesterol Education Program (NCEP)}}
		
	

}

@incollection{b3,
	
	
		,
	title={{Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults}}
	
	
		,
	journal={{JAMA}}
		
			285
			
			,
	year={2001}
		
	

}

@incollection{b4,
	
	
		,
	title={{The metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes}}
		,
	author={{
			PwfWilson
		} and {
			D' Agostino
		} and {
			RBParise
		} and {
			HSullivan
		} and {
			LMeigs
		} and {
			JB
		}}
		
		
		
		
		
	
	
		,
	journal={{Circulation}}
		
			112
			
			,
	year={2005}
		
	

}

@incollection{b5,
	
	
		,
	title={{The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intraabdominal fat}}
		,
	author={{
			DJNieves
		} and {
			MCnop
		} and {
			BRetzlaff
		}}
		
		
	
	
		,
	journal={{Diabetes}}
		
			52
			
			,
	year={2003}
		
	

}

@incollection{b6,
	
	
		,
	title={{Abdominal obesity, muscle composition, and insulin resistance in premenopausal women}}
		,
	author={{
			RRoss
		} and {
			JFreeman
		} and {
			RHudson
		} and {
			IJanssen
		}}
		
		
		
	
	
		,
	journal={{J Clin Endocrinol Metab}}
		
			87
			
			,
	year={2002}
		
	

}

@incollection{b7,
	
	
		,
	title={{Clinical review 115: effect of thyroxin therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature}}
		,
	author={{
			MDDanese
		} and {
			PWLadenson
		} and {
			CLMeinert
		} and {
			NRPowe
		}}
		
		
		
	
	
		,
	journal={{J Clin Endocrinol Metab}}
		
			85
			
			,
	year={2000}
		
	

}

@incollection{b8,
	
	
		,
	title={{Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome}}
		,
	author={{
			BLWajchenberg
		}}
	
	
		,
	journal={{Endocr Rev}}
		
			21
			
			,
	year={2000}
		
	

}

@incollection{b9,
	
	
		,
	title={{The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intraabdominal fat}}
		,
	author={{
			DJNieves
		} and {
			MCnop
		} and {
			BRetzlaff
		} and {
			CEWalden
		} and {
			JDBrunzell
		} and {
			RHKnopp
		} and {
			SEKahn
		}}
		
		
		
		
		
		
	
	
		,
	journal={{Diabetes}}
		
			52
			
			,
	year={2003}
		
	

}

@incollection{b10,
	
	
		,
	title={{Despre's JP. Hypertriglyceridemic waist. A marker of the atherogenic metabolic triad (hyperinsulinemia, hyperapolipoprotein B, small, dense LDL) in men}}
		,
	author={{
			ILemieux
		} and {
			APascot
		} and {
			CCouillard
		} and {
			BLamarche
		} and {
			ATchernof
		} and {
			NAlme Ras
		} and {
			JBergeron
		} and {
			DGaudet
		} and {
			GTremblay
		} and {
			DPrud'homme
		} and {
			ANadeau
		}}
		
		
		
		
		
		
		
		
		
		
	
	
		,
	journal={{Circulation}}
		
			102
			
			,
	year={2000}
		
	

}

@incollection{b11,
	
	
		,
	title={{Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia}}
		,
	author={{
			JPDespres
		} and {
			AGolay
		} and {
			LSjostrom
		}}
		
		
	
	
		,
	journal={{N Engl J Med}}
		
			353
			
			,
	year={2005}
		
	

}

@incollection{b12,
	
	
		,
	title={{The insluin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis}}
		,
	author={{
			HNGinsberg
		} and {
			LSHaung
		}}
		
	
	
		,
	journal={{J Cardiovasc Risk}}
		
			7
			
			,
	year={2000}
		
	

}

@incollection{b13,
	
	
		,
	title={{cloning and sequencing of the human cholesteryl ester transfer protein cDNA}}
		,
	author={{
			DDrayna
		} and {
			ASJamagin
		} and {
			JMclean
		}}
		
		
	
	
		,
	journal={{Nature}}
		
			327
			6324
			,
	year={1987}
		
	

}

@incollection{b14,
	
	
		,
	title={{Cholesteryl ester transfer protein and its plasma regulator: lipid transfer inhibitor protein}}
		,
	author={{
			REMorton
		}}
	
	
		,
	journal={{Curr Opin Lipidol}}
		
			10
			
			,
	year={1999}
		
	

}

@incollection{b15,
	
	
		,
	title={{Increased plasma cholesteryl ester transfer protein in obese subjects: a possible mechanism for the reduction of serum HDL cholesterol levels in obesity}}
		,
	author={{
			TArai
		} and {
			SYamashita
		} and {
			KHirano
		}}
		
		
	
	
		,
	journal={{Arterioscler Thromb}}
		
			14
			
			,
	year={1994}
		
	

}

@incollection{b16,
	
	
		,
	title={{Metabolic basis of hypotriglyceridemic effects of insulin in normal men}}
		,
	author={{
			RMalmstro
		} and {
			CJPackard
		} and {
			TDWatson
		}}
		
		
	
	
		,
	journal={{Arterioscler Thromb Vase Biol}}
		
			17
			
			,
	year={1997}
		
	

}

@incollection{b17,
	
	
		,
	title={{Apolipoprotein B metabolism in subjects with deficiency of apoliporoteins C-III and AI; evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo}}
		,
	author={{
			HNGinsberg
		} and {
			N-ALe
		} and {
			IJGoldberg
		}}
		
		
	
	
		,
	journal={{J Clin Invest}}
		
			78
			
			,
	year={1986}
		
	

}

@incollection{b18,
	
	
		,
	title={{Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease}}
		,
	author={{
			BLamarchc
		} and {
			ATchernof
		} and {
			Mauriege
		}}
		
		
	
	
		,
	journal={{JAMA}}
		
			279
			
			,
	year={1998}
		
	

}

@incollection{b19,
	
	
		,
	title={{Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B}}
		,
	author={{
			AChatt
		} and {
			RLBrazg
		} and {
			DLTribble
		}}
		
		
	
	
		,
	journal={{Am J Med}}
		
			94
			
			,
	year={1993}
		
	

}

@incollection{b20,
	
	
		,
	title={{The metabolic syndrome: practical guide to origins and treatment: part I}}
		,
	author={{
			PWWilson
		} and {
			SMGrundy
		}}
		
	
	
		,
	journal={{Circulation}}
		
			108
			
			,
	year={2003}
		
	

}

@incollection{b21,
	
	
		,
	title={{High density lipoproteins and coronary heart disease}}
		,
	author={{
			PJBarter
		} and {
			KARye
		}}
		
	
	
		,
	journal={{Atherosclerosis}}
		
			121
			
			,
	year={16996}
		
	

}